Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/OR/Medford
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Medford, OR

Studies commonly pay $75 to $4,500 per completed study

38 clinical trials are currently recruiting participants within 30 miles of Medford. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

38studies recruiting
3+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Medford right now

Top 25 of 38 recruiting studies, sorted by proximity — each links to its official registry page

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Phase 3 Interventional 364 participants sought
Rogue Valley Medical Center — Medford, Oregon (1.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04510597)

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

Diabetes Mellitus, Type 1 Phase 3 Interventional 150 participants sought
Velocity Clinical Research - Medford — Medford, Oregon (1.3 mi) · Sponsor: vTv Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06334133)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

Non-squamous Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Medford, Oregon (1.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06627647)

A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

Breast Cancer Phase 3 Interventional 420 participants sought
Asante Rogue Regional Medical Center — Medford, Oregon (1.3 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT05646862)

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Interventional 990 participants sought
Research Site — Grants Pass, Oregon (25.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06878261)

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Breast Cancer Phase 3 Interventional 2,250 participants sought
Hematology Oncology Associates — Medford, Oregon (1.3 mi) · Sponsor: Greenwich LifeSciences, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05232916)

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

Ovarian Cancer, Non-small Cell Lung Cancer Phase 1, Phase 2 Interventional 250 participants sought
Asante / Heimann Cancer Center — Medford, Oregon (1.3 mi) · Sponsor: Tubulis GmbH
See eligibility & contact on ClinicalTrials.gov (NCT06303505)

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis Phase 3 Interventional 1,264 participants sought
Asante Rogue Regional Medical Center — Medford, Oregon (1.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06119581)

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD) Phase 2 Interventional 987 participants sought
Research Site — Medford, Oregon (1.3 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07082738)

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathic Pain Phase 3 Interventional 1,100 participants sought
Velocity Clinical Research - Medford — Medford, Oregon (1.3 mi) · Sponsor: Vertex Pharmaceuticals Incorporated
See eligibility & contact on ClinicalTrials.gov (NCT06628908)

Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears

Full-thickness Rotator Cuff Tear N/A Observational 120 participants sought
Southern Oregon Orthopedics Research Foundation — Medford, Oregon (1.3 mi) · Sponsor: Arthrex, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05981833)

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Plaque Psoriasis Phase 3 Interventional 3,040 participants sought
Velocity Clinical Research, Medford — Medford, Oregon (1.3 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07116967)

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Multiple conditions Phase 3 Interventional 1,780 participants sought
Asante Rogue Regional Medical Center — Medford, Oregon (1.3 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT03067181)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Rogue Valley Medical Center — Medford, Oregon (1.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
Asante Rogue Regional Medical Center — Medford, Oregon (1.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05812807)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Asante Rogue Regional Medical Center — Medford, Oregon (1.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

Neurotrophic Keratopathy Phase 3 Interventional 70 participants sought
Cataract & Laser Institute of Southern Oregon — Medford, Oregon (1.3 mi) · Sponsor: ReGenTree, LLC
See eligibility & contact on ClinicalTrials.gov (NCT05555589)

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Hypercholesterolemia Phase 2 Interventional 420 participants sought
Velocity Clinical Research, Medford — Medford, Oregon (1.3 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07477704)

FiberLocker® System Augmentation of Rotator Cuff Repairs

Rotator Cuff Tear, Rotator Cuff Tears N/A Interventional 60 participants sought
Southern Oregon Orthopedics Research Foundation — Medford, Oregon (1.3 mi) · Sponsor: ZuriMED Technologies Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06918041)

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

Rhinovirus Infection Phase 2 Interventional 180 participants sought
Velocity Clinical Research - Medford — Medford, Oregon (1.3 mi) · Sponsor: Altesa Biosciences, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07610395)
Actively enrolling

Studies you may be able to join near Medford

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Medford

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Velocity Clinical Research

★ 4.2
3121 Signature Court, Medford, OR 97504
(541) 858-1018
"Friendly people. They get medication go through that help others in the long run. Testing is important. Im looking forward to seeing how the one ,t…"
— Denise Thayer, 5★

Southern Oregon University Research Center

★ 5.0
1250 Siskiyou Blvd, Ashland, OR 97520
(541) 552-7010

OnTrack Rogue Valley | Comprehensive Behavioral Health Treatment for Substance Use & Mental Health Conditions

★ 3.6 (104 reviews)
300 W Main St, Medford, OR 97501
(541) 772-1777
"Very helpful day program, lots of peer support and great content."
— Debe F, 5★

Clinical trials in Medford: what's recruiting

The Medford area currently has 38 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Medford, the most active research areas are:

  • Cancer & Oncology10 studies
  • Lungs & Breathing4 studies
  • Diabetes & Metabolism2 studies
  • Liver & Kidney1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Medford, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Medford

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Medford participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Medford?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Medford?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Medford?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Medford.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Medford typically complete one or two studies per year.

Paid clinical trials near Medford

Other metros within reach

Eugene, OR148 Salem, OR111 Portland, OR1,016 Vancouver, WA1,016 Roseville, CA634 Santa Rosa, CA143 Sacramento, CA633 Reno, NV192

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Medford Bladder Issues Due To Spinal Cord Injury in Medford All conditions

More of OR

Portland1,016 Eugene148 Salem111

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts